Key facts
- It has raised $303.2M; the latest was Later Stage VC ($117.0M) in Nov 2024.
- Notable investors include FJ Labs, TA Ventures, Trousdale Ventures, Claret Capital Partners, Redbus Ventures — 29 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 29 names
- ·Watchlist + deal alerts for Impress
- ·The full record, as it builds
Funding rounds
No funding rounds for Impress are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Impress
Provider of teeth alignment services intended to carry out a personalized diagnosis and treatment. The company provides services for unbalanced bites, crowded teeth, rotations, and interdental spaces and also offers individualized digital monitoring, enabling patients to get dental treatment at an affordable cost.
- Sector
- Healthcare
- HQ
- Barcelona, Spain
- Founded
- 2019
- Employees
- 1,200
- Website
- smile2impress.com/
- Ownership
- Privately Held (backing)
Impress doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Impress shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Impress in its N-PORT filings yet. We sweep new filings monthly.